Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·2 days ago, 08:10 AMEDIT+2.41%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·2 days ago, 07:49 AMCAI+4.03%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·2 days ago, 07:00 AMTWST+6.10%
Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slideWeekly Review·2 days ago, 06:47 AMSLS+3.07%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·2 days ago, 06:40 AMRVMD+0.62%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·2 days ago, 06:39 AMREGN+1.94%
Weekly Recap | Natera +0.23%, consensus target above spotWeekly Review·2 days ago, 06:29 AMNTRA+2.34%
Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buyWeekly Review·2 days ago, 06:12 AMLRMR-0.89%
Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buyWeekly Review·2 days ago, 05:07 AMXBI+1.24%LABD-3.54%
